Iradimed adopts clawback policy for executive compensation recovery effective Oct 2, 2023

IRADIMED CORP

Board adopted Incentive-Based Compensation Recovery Policy on Nov 2, 2023, effective Oct 2, 2023.
Policy mandates recovery of erroneously awarded incentive-based compensation from current and former executive officers.
Recovery triggered by an accounting restatement; no misconduct required for clawback.
Policy complies with Nasdaq Rule 5608 and SEC Rule 10D-1; indemnification of executive officers prohibited.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.